Your future at Roche Diabetes Care

How? Probably because they can pay these bimbos much less and replace them with similar lackeys as needed.

 

competitive bidding single payer amount announced. this is the end of our company. look out for reorg announcements

 

It is big it is ugly it is low reimbursement from the feds then commercial plans will follow. There is no way in hell Roche can survive this 72% reduction in strip reimbursement. Maybe Jill Germann saw Roche was not ready and got out before she was F-I-R-E-D or laid off.

 

The only thing that biotech did was let go of the very people who knew how to bring in revenue with the new direction of Roche and pumps and protected her meter maid dumb asses who are only draining the company and trying to lead a sales team to sell pumps when they have no clue as to how. Amazing!